Search
for
Sort by
Research 31–60 of 307
- Structural characterization of cyclosporin A, C and microbial bio-transformed cyclosporin A analog AM6 using HPLC–ESI–ion trap-mass spectrometry
- Pathways to inflammation: acne pathophysiology
- Red ginseng monograph
- Adverse cutaneous effects of psychotropic medications
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- Chemotherapy and Cutaneous Drug Reactions
- GC-MS Fatty Acid Profile and In silico Studies of Telfairia occidentalis Hook f. (Fluted Pumpkin) and Sphenostylis stenocarpa (African Yam bean) Seeds Oil on Human 5 Alpha Reductase II
- Bioavailability File: Bicalutamide
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- Poster Abstracts
- Steroidogenesis in steroid related cancers
- Synthesis and 5α-Reductase Inhibitory Activity of C21 Steroids Having 1,4-diene or 4,6-diene 20-ones and 4-Azasteroid 20-Oximes
- Mixture effects of endocrine disrupting compounds in vitro
- Non-invasive biomonitoring of infant exposure to environmental organic pollutants in north-western Spain based on hair analysis. Identification of potential sources
- Anti-inflammatory Effects in LPS-treated RAW 264.7 Cells and the Influences on Drug Metabolizing Enzyme Activities by the Traditional Herbal Formulas, Yongdamsagan-Tang and Paljung-san
- Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- Recent Approaches in the Treatment of Polycystic Ovary Syndrome: An Update
- Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review
- THE GENETICS OF CYP GENE VARIANTS IN ASSOCIATION WITH POLYCYSTIC OVARY SYNDROME: A NARRATIVE REVIEW
- Randomisierte, doppelblind Placebo-kontrollierte Studie zur Wirksamkeit eines spezifischen, CYP (Cystin, Medizinalhefe, Pantothensäure)-Komplex-haltigen Arzneimittels zur Nahrungsergänzung (Pantogar) bei Frauen 60+ mit Haarausfall
- Study of Human Leukocyte Antigen ( HLA ) in 13 cases of familial frontal fibrosing alopecia: CYP 21A2 gene p.V281L mutation from congenital adrenal hyperplasia linked to HLA class I haplotype HLA ‐ A*33:01 ; B*14:02; C*08:02 as a genetic marker
- Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone.
- Preventive effects of cedrol against alopecia in cyclophosphamide-treated mice
- A study on the extracts of Cuscuta reflexa Roxb. in treatment of cyclophosphamide induced alopecia
- Effect of perfluorooctanesulfonate exposure on steroid hormone levels and steroidogenic enzyme activities in juvenile <i>Silurana tropicalis</i>
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- A novel regio-specific cyclosporin hydroxylase gene revealed through the genome mining of <i>Pseudonocardia autotrophica</i>
- S100A8 induces cyclophosphamide-induced alopecia via NCF2/NOX2-mediated ferroptosis
- High-resolution mass spectrometric investigation of the phase I and II metabolites of finasteride in pig plasma, urine and bile